# US 2012/0083763 A1 · Method for Delivering a Topical Agent to a Nasaogastric Passage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083763 A1
- Document ID: US20120083763A1
- Status: Published application
- Kind: A1
- Application number: 12/897,656
- Filed: 2010-10-04
- Published: 2012-04-05
- Earliest claimed: 2010-10-04
- Inventors: Edwin A. Diaz; Kristianne Diaz; Robert A. Diaz
- Web page: https://patentgrep.com/patent/US20120083763A1

## CPC

- A61M 31/00: Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008})
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

The present invention is directed to a method for delivering a topical agent to a nasogastric passage comprising: introducing a nasogastric tube into the nasogastric passage, the nasogastric tube comprising means for delivering the topical agent to the nasogastric passage; positioning the nasogastric tube such that the means for delivering the topical agent is positioned adjacent to a target area in the nasogastric passage; and delivering a therapeutic amount of the topical local anesthetic agent to the target area of the nasogastric passage.

## Claims

### Claim 1

A method for delivering a topical agent to a nasogastric passage comprising:
introducing a nasogastric tube into the nasogastric passage, the nasogastric tube comprising means for delivering the topical agent to the nasal passage;
positioning the nasogastric tube such that the means for delivering the topical agent is positioned adjacent to a target area in the nasogastric passage; and
delivering the topical agent to the target area of the nasogastric passage.

### Claim 2 (depends on 1)

The method according to claim 1 wherein a portion of the nasogastric tube comprises means for delivering the topical local anesthetic agent.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the target area comprises the nasal-pharynx passageway.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the target area comprises the nasal-pharynx passageway, the nasal cavity, or combinations thereof.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the topical agent comprises an anesthetic compound, an anti-inflammatory compound, a decongestant compound, or combinations thereof.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the anesthetic compound comprises lidocaine. xylocaine, or combinations thereof.

### Claim 7 (depends on 5)

The method according to claim 5, wherein the anti-inflammatory compound comprises fluticasone.

### Claim 8 (depends on 5)

The method according to claim 5, wherein the decongestant compound comprises phenylephrine.

### Claim 9 (depends on 1)

The method according to claim 1, wherein a portion of the nasogastric tube is disposed within the gastrointestinal tract.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the portion of the nasogastric tube is disposed within the stomach cavity.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the nasogastric tube comprises an inner tube that is disposed within an outer tube, the outer tube having a diameter that is greater than the inner tube, and wherein the means for delivering the topical agent comprises perforations in a portion of the outer tube.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the outer tube of the nasogastric tube is connected to an apparatus for dispensing the topical agent.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the means for delivering the topical local anesthetic comprises a time-release topical agent.

### Claim 14

A method for delivering a topical agent to a nasogastric passage comprising:
introducing a nasogastric tube into the nasogastric passage wherein the nasogastric tube comprises an inner tube that is disposed within an outer tube, the outer tube having a diameter that is greater than the inner tube, and wherein the outer tube of the nasogastric tube further comprises a perforated portion;
positioning the perforated portion of the nasogastric tube adjacent a target area in the nasogastric passage; and
delivering a therapeutic amount of said topical agent to the target area of the nasogastric passage.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the topical agent comprises an anesthetic compound, an anti-inflammatory compound, a decongestant compound, or combinations thereof.

### Claim 16 (depends on 14)

The method according to claim 14, wherein a portion of the nasogastric tube is disposed within the gastrointestinal tract.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the portion of the nasogastric tube is disposed within the stomach cavity.

### Claim 18 (depends on 14)

The method according to claim 14, wherein the target area comprises the nasal-pharynx passageway, the nasal cavity, or combinations thereof.

### Claim 19 (depends on 14)

The method according to claim 14, wherein the topical agent comprises lidocaine. xylocaine, or combinations thereof.

### Claim 20 (depends on 14)

The method according to claim 14, wherein the topical agent comprises fluticasone, phenylephrine, or combinations thereof.
